Radiology in Obstetrics Flashcards
1
Q
x-rays: are they safe?
A
- “All-or-none” phenomenon
- Location of irradiation
- Amount of radiation
- Timing (during pregnancy) of exposure
2
Q
harmful effects of ionizing radiation
A
- Cell death and birth defects (Teratogenesis)
- Carcinogenesis
- Genetic effects
3
Q
HDR and Carcinogenesis: weak data
A
- Unclear risk, probably very small
- At 10-20 mGy, 1/2000 develop childhood leukemia
- Background risk is 1/3000
- Non-irradiated siblings also have higher risk of leukemia
- Termination of pregnancy should not be based on exposure to typical dosing
4
Q
genetic effects of radiation
A
- May increase frequency of natural mutations, not create de novo mutations
- No increased risk of genetic disorders has been noted in any human population at any dose
- “Little or no evidence exists for estimating the frequency or magnitude of genetic effects on future generations”
5
Q
nuclear medicine and pregnancy
A
- “Tagging” a chemical agent with a radioisotope
- Fetal exposure depends on radioisotope’s physical and biochemical properties
-
Tc 99m – used in brain, bone, renal, CV scans
- Exposure < 0.5 rads
- VQ Scans – Tc 99m for perfusion, 127Xe or 133Xe for ventilation
- Exposure ~ 50 mrad (0.05 rads)
-
Tc 99m – used in brain, bone, renal, CV scans
6
Q
MRI contrast agents
A
- Gadolinium and iron oxide based agents are most commonly used
- Gadolinium is associated with nephrogenic systemic fibrosis (NSF), especially in “free” form
- AKA nephrogenic fibrosing dermopathy (NFD)
- Disease of fibrosis of the skin and internal organs
7
Q
safety of ultrasound in pregnancy
A
- Sound waves, not ionizing radiation
- No reports of adverse fetal effects
- FDA arbitrarily limits energy exposure
8
Q
indications for first trimester ultrasound
A
- Confirm fetal viability and dates
- Rule out ectopic pregnancy
- Diagnose multifetal pregnancy
- Guidance for removal of IUD
- Rule out molar pregnancy
- Guidance for chorionic villous sampling
- Nuchal translucency testing
9
Q
pregnancy dating
A
- Error of ultrasound:
- ≤ 8-6/7 weeks: 5 days
- 9 to 15-6/7 weeks: 7 days
- 16 to 21-6/7 weeks: 10 days
- 22 to 27-6/7 weeks: 14 days
- 28 to term: 21 days
- Assessment of fetal growth patterns linked to ultrasound error
10
Q
pregnancy with IUD
A
- Higher risk of ectopic
- 50-60% risk of miscarriage if left inside uterus
- String retraction hampers removal
11
Q
ectopic pregnancy and ultrasound
A
- Most ectopic pregnancies are tubal
- Presentation: 7-8 weeks
- Clinical triad: Pain, bleeding, amenorrhea
- Ultrasound cannot definitively rule OUT an ectopic pregnancy, but can rule IN an intrauterine pregnancy
- Other less common sites: cornual, cervical
12
Q
molar pregnancy and ultrasound
A
- Molar gestation – neoplastic placental growth
- Fetus present (partial) or absent (complete)
- Inheritance: uniparental disomy
- Lab: high levels of HCG
- Symptoms: hyperemesis, hyperthyroidism
- US: “Snowstorm” or “Grape-like” clusters
- High incidence of fetal CNS anomalies
- Uniparental disomy – both chromosomes come from dad or both come from mom
13
Q
CVS and ultrasound
A
- Biopsy of placental tissue at 10-13 weeks
- Diagnoses chromosomal or genetic disorders for which DNA testing is available
- Ultrasound guides needle/catheter into placental tissue
14
Q
fetal nuchal translucency
A
- 11.5 and 14.5 weeks
- Abnormal edema associated with chromosomal and fetal structural abnormalities
- Down syndrome
- Fetal anomalies mostly cardiac
- If pt has test that shows nuchal translucency that is greater than 3, this is BAD
15
Q
1st trimester cystic hygroma
A
- Commonly associated with Downs, trisomy 18, and turner syndrome
16
Q
2nd trimester ultrasound uses
A
- Assessing gestational age
- Multifetal pregnancy detection
- Screening for fetal anomalies
- Placental localization and evaluation
- Amniotic fluid evaluation
- Guidance for amniocentesis
17
Q
components of a 2nd trimester ultrasound
A
- Gestational age / fetal growth
- Fetal position
- Fetal number
- Placental location
- Amniotic fluid volume
- Uterine evaluation – fibroids, anomalies
- Cervical evaluation
- Fetal anatomy
18
Q
placenta
A
- Where is it?
- Anterior
- Posterior
- Fundal
- Covering the cervical os
- Is it abnormal?
- Molar pregnancy
- Has it separated?
- Abruptio placenta
19
Q
placenta previa
A
- Higher incidence in assisted reproductive technologies (insemination, IVF)
20
Q
placental location and appearance
A
-
Placenta previa
- Complete, partial or marginal
- Common in 2nd (5%) and rare in 3rd trimester (0.5%)
- Higher incidence in multiparas, elderly, previous cesarean section or abortion
- May detect retroplacental or retromembranous clot – abruptio placenta
- If placenta is within 2 cm of the os, the possibility of bleeding is 50%
21
Q
amniotic fluid assessment
A
- Increased: Polyhydramnios
- Diabetes
- Upper GI tract obstruction
- Chromosomal abnormalities
- Muscular lesions affecting swallowing
- Decreased: Oligohydramnios
- Rupture of the membranes
- Absent fetal renal tissue or lower urinary tract obstruction
- Intrauterine growth restriction
22
Q
uterine evaluation during obstetical sonography
A
- Overall shape and size
- Presence of anomalies
- Uterus didelphys (including double cervix)
- Uterine septa, bicornuate uterus
- Presence of tumor – leiomyoma
23
Q
cervical evaluation during 2nd trimester
A
- Normal cervical length: > 2.5 cm
- Borderline area: 2.0-2.5 cm
- Abnormally short: < 2.0 cm
- Normal shortening process during gestation
- Most helpful evaluation between 18-22 weeks
- Funneling
- “Hourglassing” membranes
- Placement of cervical cerclage
24
Q
fetal anatomic survey
A
- Systematic survey for fetal anomalies
- Performed usually between 16 and 22 week
- CNS
- Cardiopulmonary
- Gastrointestinal
- Genitourinary
- Musculoskeletal
- Umbilical cord
- Fetal exterior
25
fetal anatomy: CNS and Spine
* Cerebral ventricles
* Posterior fossa and cerebellum
* Cavum septum pellucidum
* Cranium
* Encephalocele
* Hypo- and hypertelorism
* Spina bifida
* Myelocele
* Myelomeningocele
26
cardiopulmonary assessment
* 4 chamber heart, outflow tracts
* Echogenic foci
* Cardiac masses – myxoma, rhabdomyoma
* Pulmonary evaluation
* Diaphragmatic herniation
* Masses:
* Cystic adenomatoid malformations (CCAM)
* Bronchopulmonary sequestration
* Effusions
27
gastrointestinal assessment
* GI tract obstruction
* Absence of stomach “bubble”
* Tracheo-esophageal fistula
* “Double bubble”
* Duodenal atresia
* Anal atresia
* Ascites
* “Echogenic” bowel – brightness = bone brightness
* Trisomy 21
* Cystic fibrosis
* Intrauterine bleeding
* Intrauterine infections – CMV, toxoplasmosis
28
genitournary assessment
* Normal anatomy
* Kidneys and bladder seen
* Ureters and urethra not seen
* Abnormal:
* Dilated renal pelvis – obstructive, “flaccid”
* Obstructions: UPJ, UVJ, urethral (bladder outlet), hydronephrosis
* Renal, ovarian cysts
* Hypospadias, penile anomalies
* Cystic renal changes
29
umbilical cord assessment
* Number of vessels
* 2 vessel cord associated with chromosomal, skeletal, GU tract abnormalities – up to 50%
* Insertion site into abdomen
* Defects
* Gastroschisis
* Omphalocele
30
musculoskeletal assessment
* Calvarium
* Long bones
* Presence or absence
* Length
* Bowing
* Fractures
* Digits – Number and orientation
* Abnormalities: - skeletal dysplasias, spondylolystheses, ichythyoses
31
fetal exterior/integument assessment
* Craniofacial
* Cleft lip and palate
* Cystic hygroma
* Teratomas
* Sacrococcygeal
32
3rd trimester assessment
* Fetal growth
* Biometry
* Fluid assessment: AFI
* Fetal well-being
* Biophysical profile
* Doppler studies
* Fetal pulmonary maturity studies
* LBC, SA Ratio, LS ratio, PG level
33
macrosomia greater than 90th percentile for GA
* Often associated with diabetes
* CPD/Shoulder dystocia
* US widely used to estimate fetal weight
* Cesarean section recommended for:
* 4750 gm (non-diabetic)
* 4250 gm (diabetic)
34
fetal growth assessment: IUGR \<10th percentile for GA
* Chromosomal abnormalities
* Renal disease and hypertension
* Connective tissue diseases – lupus
* Perinatal infections – CMV, toxoplasmosis, etc.
* Thrombophilia – clotting abnormalities
* Placental abnormalities
35
fetal well-being by ultrasound: fluid assessment
* Amniotic fluid volume is an indicator of fetal renal output
* Decreased amniotic fluid is associated with increased rate of perinatal mortality
36
biophysical profile
* Excellent predictor of fetal well being
* 4 ultrasound parameters + NST
* Fetal breathing
* Fetal tone
* Fetal movement
* Amniotic fluid volume (2 cm pocket)
* 2 points for each normal parameter
* Normal: ≥ 7 points
37
MRI and pregnancy
* Magnets alter energy state of hydrogen protons
* May be helpful in diagnosis of fetal CNS defects and IUGR
* May also help in detecting placenta accreta
* Some agencies advise against use in 1st trimester but no reports of adverse effects